These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 14645446)
21. Capecitabine plus oxaliplatin vs infusional 5-fluorouracil plus oxaliplatin in the treatment of colorectal cancer. Pro: The CapeOx regimen is preferred over FOLFOX. Chang DZ; Abbruzzese JL Clin Adv Hematol Oncol; 2005 May; 3(5):400-4. PubMed ID: 16167013 [No Abstract] [Full Text] [Related]
22. Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie. Al-Batran SE; Hartmann JT; Probst S; Schmalenberg H; Hollerbach S; Hofheinz R; Rethwisch V; Seipelt G; Homann N; Wilhelm G; Schuch G; Stoehlmacher J; Derigs HG; Hegewisch-Becker S; Grossmann J; Pauligk C; Atmaca A; Bokemeyer C; Knuth A; Jäger E; J Clin Oncol; 2008 Mar; 26(9):1435-42. PubMed ID: 18349393 [TBL] [Abstract][Full Text] [Related]
23. [Individualized therapy of synchronous ovarian and colon cancers with lymph]. Deme D; Bishr AM; Nizar J; Telekes A Orv Hetil; 2015 Jun; 156(23):939-43. PubMed ID: 26027602 [TBL] [Abstract][Full Text] [Related]
24. Hepatic arterial infusion chemotherapy using fluorouracil followed by systemic therapy using oxaliplatin plus fluorouracil and leucovorin for patients with unresectable liver metastases from colorectal cancer. Seki H; Ozaki T; Shiina M Cardiovasc Intervent Radiol; 2009 Jul; 32(4):679-86. PubMed ID: 19296157 [TBL] [Abstract][Full Text] [Related]
25. Hepatic arterial infusion of oxaliplatin and L-folinic acid-modulated 5-fluorouracil for colorectal cancer liver metastases. Neyns B; Van Nieuwenhove Y; Aerts M; Fontaine C; Vermeij J; Schallier D; Decoster L; De Mey J; Vandenbroucke F; Hoorens A; Delvaux G; De Gréve J Anticancer Res; 2006; 26(1B):611-9. PubMed ID: 16739329 [TBL] [Abstract][Full Text] [Related]
26. Prediction of prognosis and surgical indications for pulmonary metastasectomy from colorectal cancer. Iizasa T; Suzuki M; Yoshida S; Motohashi S; Yasufuku K; Iyoda A; Shibuya K; Hiroshima K; Nakatani Y; Fujisawa T Ann Thorac Surg; 2006 Jul; 82(1):254-60. PubMed ID: 16798225 [TBL] [Abstract][Full Text] [Related]
27. Carcinoembryonic antigen as a prognostic and monitoring test in colorectal carcinoma. Chatterji A; Batabyal SK Indian J Pathol Microbiol; 1987 Jan; 30(1):81-7. PubMed ID: 3679340 [No Abstract] [Full Text] [Related]
28. Transient CEA increase at start of oxaliplatin combination therapy for metastatic colorectal cancer. Sørbye H; Dahl O Acta Oncol; 2004; 43(5):495-8. PubMed ID: 15360055 [TBL] [Abstract][Full Text] [Related]
29. Combined effects of 5-fluorouracil, folinic acid and oxaliplatin on the expression of carcinoembryonic antigen in human colon cancer cells: pharmacological basis to develop an active antitumor immunochemotherapy. Prete SP; Turriziani M; Massara MC; De Rossi A; Correale P; De Vecchis L; Torino F; Bonmassar L; Aquino A J Exp Clin Cancer Res; 2008 May; 27(1):5. PubMed ID: 18577244 [TBL] [Abstract][Full Text] [Related]
30. Expression of an unusual isozyme of lactate dehydrogenase in the serum of cancer patients and comparison with carcinoembryonic antigen. Manly KF; Petrelli N; Anderson GR; Emrich LJ; Herrera L; Mittelman A Cancer Res; 1987 Nov; 47(22):6156-60. PubMed ID: 3664517 [TBL] [Abstract][Full Text] [Related]
32. [II. Postoperative adjuvant chemotherapy for colon cancer. 2. Oxaliplatin combination does not help better treatment outcome]. Shimada Y Gan To Kagaku Ryoho; 2012 Nov; 39(11):1646-9. PubMed ID: 23243702 [No Abstract] [Full Text] [Related]
34. [Follow-ups after colorectal cancer]. Wählby L Tidsskr Nor Laegeforen; 1998 Jun; 118(16):2541. PubMed ID: 9667137 [No Abstract] [Full Text] [Related]
35. Lactate metabolism in patients with metastatic colorectal cancer. Holroyde CP; Axelrod RS; Skutches CL; Haff AC; Paul P; Reichard GA Cancer Res; 1979 Dec; 39(12):4900-4. PubMed ID: 498115 [No Abstract] [Full Text] [Related]
36. Mucinous adenocarcinoma of the ovary. Sholi A; Martino MA; Pirigyi M; Rosenblum NG; Markman M; Peterson CS; Bradbury AR; Morris GJ Semin Oncol; 2010 Aug; 37(4):314-20. PubMed ID: 20816501 [No Abstract] [Full Text] [Related]
37. [Neoplasm markers useful for diagnosis and monitoring of colonic neoplasms]. Ławicki S; Mroczko B; Szmitkowski M Postepy Hig Med Dosw; 2002; 56(5):617-34. PubMed ID: 12596691 [TBL] [Abstract][Full Text] [Related]
38. Protein markers in disease (3). Carcinoembryonic antigen as a tumour marker. Sturgeon CM J R Coll Surg Edinb; 1978 Sep; 23(5):319-25. PubMed ID: 702421 [No Abstract] [Full Text] [Related]
39. [Significance of carcinoembryonic antigen in the monitoring of colorectal cancer]. Lagache G Verh K Acad Geneeskd Belg; 1980; 42(1):60-73. PubMed ID: 7445709 [No Abstract] [Full Text] [Related]
40. Rising carcinoembryonic antigen titers in colorectal carcinoma: an indication for the second-look procedure. Nicholson JR; Aust JC Dis Colon Rectum; 1978 Apr; 21(3):163-4. PubMed ID: 648299 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]